Table 4

The associations between LS7 metrics and CVD-related biomarkers in men, n=2604

hsCRP
(mg/L)
D-dimer
(μg/mL)
Fibrinogen
(mg/dL)
Homocysteine
(μmol/L)
hs-cTnT
(ng/L)
NT-ProBNP
(pg/mL)
IL-6*
(pg/mL)
Smoking
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate−0.16
(−0.50, 0.17)
−0.17
(−0.45, 0.11)
−0.04
(−0.10, 0.02)
0.16
(−0.25, −0.07)
−0.07
(−0.25, 0.12)
0.52
(−0.86, −0.19)
0.21
(−0.42, −0.005)
 Ideal−0.27
(−0.39, 0.15)
0.17
(-0.27, - 0.07)
0.05
(−0.07, −0.03)
0.05
(−0.08, −0.02)
0.02
(−0.04, 0.08)
0.15
(−0.27, −0.03)
0.19
(−0.27, −0.12)
Body mass index
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate0.50
(−0.59, −0.40)
0.11
(−0.20, −0.03)
0.06
(−0.08, −0.05)
−0.01
(−0.04, 0.01)
0.17
(−0.23, −0.12)
0.07
(−0.02, 0.17)
0.30
(−0.36, −0.24)
 Ideal0.80
(−0.92, −0.69)
0.17
(−0.26, −0.07)
0.08
(−0.10, −0.06)
−0.02
(−0.05, 0.01)
0.29
(−0.35, −0.23)
0.25
(0.14, 0.36)
0.37
(−0.43, −0.30)
Physical activity
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate0.09
(−0.04, 0.23)
−0.06
(−0.17, 0.06)
−0.002
(−0.03, 0.02)
−0.01
(−0.05, 0.02)
−0.07
(−0.14, 0.01)
0.03
(−0.10, 0.17)
−0.02
(−0.10, 0.07)
 Ideal−0.03
(−0.14, 0.07)
−0.05
(−0.13, 0.04)
0.02
(−0.04, −0.004)
0.02
(−0.05, −0.00)
0.07
(−0.13, −0.02)
0.05
(−0.05, 0.15)
0.14
(−0.20, −0.07)
Diet
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate0.11
(−0.19, −0.02)
0.002
(−0.07, 0.07)
−0.01
(−0.03, 0.00)
−0.003
(−0.02, 0.02)
−0.02
(−0.07, 0.02)
0.04
(−0.04, 0.12)
0.05
(−0.10, −0.003)
 Ideal−0.57
(−1.25, 0.11)
−0.50
(−1.07, 0.07)
0.01
(−0.12, 0.14)
0.06
(−0.11, 0.24)
−0.17
(−0.54, 0.20)
0.31
(−0.36, 0.98)
−0.14
(−0.56, 0.27)
Total cholesterol
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate−0.03
(−0.17, 0.11)
0.01
(−0.11, 0.12)
0.04
(−0.06, −0.01)
−0.003
(−0.04, 0.03)
0.10
(−0.18, −0.02)
−0.09
(−0.22, 0.05)
0.08
(−0.01, 0.16)
 Ideal−0.01
(−0.15,0.13)
0.05
(−0.06, 0.17)
0.05
(−0.08, −0.03)
−0.006
(−0.04, 0.03)
0.10
(−0.17, −0.02)
0.19
(0.05, 0.32)
0.17
(0.08, 0.25)
Blood pressure
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate−0.10
(−0.20, 0.01)
−0.06
(−0.14, 0.03)
−0.01
(−0.03, 0.004)
0.03
(−0.06, −0.005)
0.12
(−0.18, −0.07)
0.37
(−0.47, −0.27)
0.07
(−0.13, −0.01)
 Ideal0.23
(−0.34, −0.13)
−0.01
(−0.10, 0.08)
0.03
(−0.05, −0.01)
0.04
(−0.07, −0.02)
0.22
(−0.27, −0.16)
0.40
(−0.50, −0.30)
0.09
(−0.16, −0.03)
Blood glucose
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate0.07
(−0.08, 0.22)
0.03
(−0.09, 0.16)
−0.01
(−0.04, 0.02)
0.04
(−0.003, 0.08)
0.23
(−0.31, −0.15)
−0.06
(−0.21, 0.09)
−0.04
(−0.14, 0.05)
 Ideal0.17
(−0.30, −0.04)
0.04
(−0.07, 0.15)
0.03
(−0.06, −0.01)
0.01
(−0.02, 0.05)
0.36
(−0.43, −0.29)
0.04
(−0.09, 0.17)
0.15
(−0.23, −0.07)
  • *For IL-6, n=2546.

  • CVD, cardiovascular disease;hsCRP, high-sensitivity C-reactive protein; hs-cTnT, high-sensitivity cardiac troponin T;IL-6, interleukin 6; LS7, Life’s Simple 7; NT-proBNP, N-terminal pro B-type natriuretic peptide.